Genesis recently launched an innovative collaboration between its Pulmonary Medicine and Thoracic Surgery departments to improve surgical treatment of lung cancer. The joint program utilizes advanced robotic bronchoscopy technology to mark lung cancers, which enables precision robotic-assisted surgical removal of small tumors.

“By integrating robotic bronchoscopy into our approach, we offer a more precise and minimally invasive procedure, improving diagnosis and treatment,” said James Adamo, M.D., F.C.C.P., Fellowship-trained and Board-certified, Pulmonary/Critical Care Medicine at Genesis HealthCare System.

This approach marks a significant advancement in the treatment of lung cancer, offering patients more accurate and less invasive options for surgery. The multidisciplinary team can better locate and target lung tumors, improving outcomes and minimizing recovery times.

“The ability to mark tumors before surgery, using robotic technology, allows us to surgically remove them with unmatched precision,” said Edmund Kassis, M.D., Fellowship-trained and Board-certified Thoracic Surgeon and Medical Director of Thoracic Surgery at the Genesis Heart & Vascular Institute. “This enhances our ability to remove cancerous tissue while preserving healthy lung tissue, which is critical for the patient’s recovery and quality of life.”

This partnership marks a significant step forward in the fight against lung cancer, combining the expertise of Genesis departments to provide cutting-edge care. The joint program is now available to patients.